Moral Distress in Oncology Practice Needs Tackling Head-on
Moral distress from being unable to provide appropriate care or being forced into making questionable decisions is common in oncology, and it needs to be addressed.
Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moral distress from being unable to provide appropriate care or being forced into making questionable decisions is common in oncology, and it needs to be addressed.
The FLT3 inhibitor, taken during chemotherapy and continued as a single agent for up to 3 years, significantly improved survival compared with standard chemotherapy.
On three floors of Cambridge Tower A at The University of Kansas Health System in Kansas City, patients being treated for blood cancers have a dedicated space that not only keeps them safe during immune system comprising treatments, but also provide feelings of comfort and compassion.
A new study found that among a subgroup of patients with hematologic/solid cancers and COVID-19, the time to symptom improvement was shorter and overall survival was better with plasma therapy.